Skip to main content
Year archive

ANATARA LIFESCIENCES LTD — 2025 filings

All 50 regulatory filings released by ANATARA LIFESCIENCES LTD (ANR) in 2025, sourced directly from the official regulator.

50 Filings
2025 Period
2025 filings (50)
Filing Released Lang
Company Update 3 pages 215.7KB
Capital/Financing Update
2025-12-16 English
Notification of cessation of securities - ANR 4 pages 14.8KB
Share Issue/Capital Change
2025-12-10 English
Change of Director Interest Notices x 3 7 pages 513.6KB
Director's Dealing
2025-12-10 English
Change of Director Interest Notices 7 pages 447.9KB
Director's Dealing
2025-11-26 English
Issue of Tranche 2 Placement Shares 2 pages 250.6KB
Capital/Financing Update
2025-11-25 English
Application for quotation of securities - ANR 6 pages 18.5KB
Share Issue/Capital Change
2025-11-25 English
Notification regarding unquoted securities - ANR 6 pages 20.3KB
Share Issue/Capital Change
2025-11-25 English
Notification of cessation of securities - ANR 4 pages 14.8KB
Regulatory Filings
2025-11-24 English
Chair's Address to Shareholders 3 pages 193.0KB
AGM Information
2025-11-19 English
2025 AGM Presentation 9 pages 828.0KB
AGM Information
2025-11-19 English
Results of Meeting 2 pages 408.8KB
Declaration of Voting Results & Voting Rights Announcements
2025-11-19 English
Notification of cessation of securities - ANR 4 pages 14.8KB
Share Issue/Capital Change
2025-11-13 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 512.9KB
Interim / Quarterly Report Q1 2026
2025-10-22 English
Annual Report to shareholders 64 pages 2.6MB
Annual Report FY 2025
2025-10-16 English
Appendix 4G and Corporate Governance Statement 26 pages 820.1KB
Governance Information
2025-10-16 English
Notice of Annual General Meeting/Proxy Form 40 pages 642.9KB
AGM Information
2025-10-16 English
Issue of Tranche 1 Placement Shares 2 pages 256.6KB
Capital/Financing Update
2025-10-07 English
Application for quotation of securities - ANR 6 pages 18.5KB
Share Issue/Capital Change
2025-10-07 English
Anatara receives firm commitments for $1.2m Placement 3 pages 268.9KB
Capital/Financing Update
2025-09-30 English
Proposed issue of securities - ANR 5 pages 18.9KB
Capital/Financing Update
2025-09-30 English
Proposed issue of securities - ANR 5 pages 18.8KB
Capital/Financing Update
2025-09-30 English
Board Changes 2 pages 171.7KB
Board/Management Information
2025-09-28 English
Trading Halt 2 pages 265.1KB
Regulatory Filings
2025-09-28 English
Appendix 3X 2 pages 281.7KB
Director's Dealing
2025-09-28 English
Appendix 3Z 2 pages 246.5KB
Director's Dealing
2025-09-28 English
Anatara Annual General Meeting & Director Nominations 2 pages 169.5KB
AGM Information
2025-09-14 English
Pause in Trading 1 page 115.1KB
Regulatory Filings
2025-09-04 English
Response to ASX Price Query 4 pages 468.2KB
Regulatory Filings
2025-09-04 English
Notification of cessation of securities - ANR 4 pages 14.8KB
Share Issue/Capital Change
2025-08-17 English
Appendix 4E & Financial Report 30 June 2025 61 pages 1.9MB
Regulatory Filings
2025-08-12 English
Conversion of Performance Rights 2 pages 217.2KB
Capital/Financing Update
2025-08-03 English
Application for quotation of securities - ANR 6 pages 18.5KB
Share Issue/Capital Change
2025-08-03 English
Quarterly Activities/Appendix 4C Cash Flow Report 13 pages 752.9KB
Interim / Quarterly Report Q4 2025
2025-07-28 English
Anatara receives $969,455 in R&D Tax Incentive for FY25 2 pages 175.5KB
Capital/Financing Update
2025-07-27 English
Company Update 4 pages 306.5KB
Capital/Financing Update
2025-07-08 English
Change in substantial holding from TEK 4 pages 191.5KB
Major Shareholding Notification
2025-06-30 English
Hong Kong Patent Granted for GaRP 3 pages 245.7KB
Regulatory Filings
2025-05-18 English
Phase II GaRP-IBS Trial Internal Analyses of Data Subsets 18 pages 1.1MB
Capital/Financing Update
2025-05-15 English
Funding Advance on R&D Refund 2 pages 239.1KB
Capital/Financing Update
2025-04-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 572.5KB
Interim / Quarterly Report Q3 2025
2025-04-29 English
Phase II GaRP-IBS Trial Headline Analysis of Results 9 pages 414.0KB
Regulatory Filings
2025-04-16 English
Phase II GaRP-IBS Trial & Anti-Obesity Project Updates 4 pages 306.0KB
Investor Presentation
2025-03-09 English
Initial Director's Interest Notice 2 pages 145.6KB
Director's Dealing
2025-03-06 English
Final Director's Interest Notice 2 pages 145.9KB
Director's Dealing
2025-03-06 English
Trading Halt 2 pages 284.5KB
Regulatory Filings
2025-03-05 English
Board Changes 2 pages 175.2KB
Board/Management Information
2025-02-27 English
Appendix 4D & Half Year Report 31 December 2024 25 pages 986.2KB
Interim / Quarterly Report H1 2025
2025-02-24 English
Phase II GaRP-IBS Trial & Anti-Obesity Project Updates 3 pages 303.5KB
Capital/Financing Update
2025-02-19 English
Australian Patent Granted for GaRP Product 3 pages 298.8KB
Regulatory Filings
2025-01-27 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 618.2KB
Interim / Quarterly Report Q2 2025
2025-01-14 English